Checkpoint Therapeutics, Inc

Company Listings from SPi: Checkpoint Therapeutics, Inc

You are here: Home >> SPi Company Listings >> Checkpoint Therapeutics, Inc

 

Checkpoint Therapeutics, Inc

Website:
http://

Search for other references to "checkpoint" on SPi News

Latest Checkpoint Therapeutics, Inc News

Checkpoint Therapeutics Reports Full-Year 2018 Financial Results and Recent Corporate Highlights NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused...... 11:30 GMT Friday 15th March 2019

Checkpoint Therapeutics Announces Issuance of Two New Patents for EGFR Inhibitor CK-101 NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused o...... 12:30 GMT Wednesday 13th March 2019

Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301 NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on...... 13:30 GMT Monday 7th January 2019

Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights NEW YORK, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on...... 12:00 GMT Friday 2nd November 2018

Checkpoint Therapeutics Appoints Christian Béchon to its Board of Directors NEW YORK, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on...... 13:00 GMT Tuesday 16th October 2018

Checkpoint Therapeutics to Present at Ladenburg Thalmann 2018 Healthcare Conference NEW YORK, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a Fortress Biotech (NASDAQ: FBIO) company, today announced that Jame...... 13:00 GMT Thursday 27th September 2018

Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-101 NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused o...... 13:00 GMT Tuesday 25th September 2018

Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101 NEW YORK, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused o...... 12:30 GMT Thursday 6th September 2018

Checkpoint Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference NEW YORK, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a Fortress Biotech (NASDAQ: FBIO) company, today announced that James...... 13:00 GMT Thursday 30th August 2018

Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on...... 13:00 GMT Monday 13th August 2018

Buy Checkpoint Therapeutics, Inc
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us